N.Y. PBH Law § 3220
This is the official text of N.Y. PBH Law § 3220, part of New York’s PBH Law — part of the compiled statutory law of New York, published by the state as "PBH Law." Browse the sections below, each linked to its official government source.
Not legal advice. This page reproduces the official text of a government statute for reference only. Laws change, and how a statute applies depends on your specific facts. For advice about your situation, consult a licensed attorney in your state.
Findings
Official statutory text
§ 3220. Findings. The legislature finds that new techniques of\ngenetic manipulation which allow researchers to accomplish exchanges of\ngenetic material between unlike organisms offer great potential for\nexpanding human knowledge of genetics but also may present significant\nrisks to public health, to the environment and to the health of research\nworkers. These experiments are being conducted at research institutions\nin New York, including universities, hospitals and industrial\nfacilities. Industry plans to mass-produce recombinant organisms should\nsuch organisms be found to have commercial uses. Such research and\nproduction should only be conducted under safe conditions as prescribed\nby the commissioner.\n
Status: in_force · Read it on the official government site
Need a lawyer in New York?
Find a New York lawyer
About this page: Statute text is reproduced from official government publishers via the
Open US Law dataset
(Vaquill AI, snapshot v2026.08, CC BY 4.0). Primary legislative text like this is public domain under the government-edicts doctrine
(Georgia v. Public.Resource.Org, 2020). We link every section back to its official source so you can verify it independently.